Skip to main content
Sally Arai, MD, Hematology, Stanford, CA, Stanford Health Care

SallyAraiMD

Hematology Stanford, CA

Hematologic Oncology

Assistant Professor, Medicine - Blood & Marrow Transplantation, Stanford University Medical Center

Dr. Arai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arai's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1995 - 1998
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1992 - 1995
  • George Washington University
    George Washington UniversityResidency, Surgery, 1991 - 1992
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2025
  • IL State Medical License
    IL State Medical License 2001 - 2005
  • MD State Medical License
    MD State Medical License 1999 - 2004
  • NY State Medical License
    NY State Medical License 1994 - 2004
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Immune Reconstitution and Long-Term Outcomes Following Allo-HCT with TLI-ATG and Post-Transplant Rituximab
    Sally Arai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
    Sally Arai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
    Sally Arai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Roberto Alejandro Sica, MD, a Hematologist-Oncologist with Montefiore Medical Center
    Roberto Alejandro Sica, MD, a Hematologist-Oncologist with Montefiore Medical CenterJanuary 5th, 2022
  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
  • Meet Your Match: A Bone Marrow Transplantation Leads to an International Friendship
    Meet Your Match: A Bone Marrow Transplantation Leads to an International FriendshipMay 10th, 2018

Professional Memberships

Hospital Affiliations